
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| EB | 1,385 | 81.8% | -1.62 | 452 | 95.2% |
| BU(R) | 242 | 14.3% | -4.60 | 10 | 2.1% |
| CentralBrain-unspecified | 65 | 3.8% | -2.32 | 13 | 2.7% |
| gL(R) | 2 | 0.1% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns ER3a_d | % In | CV |
|---|---|---|---|---|---|
| ER3a_a (L) | 8 | GABA | 158.5 | 18.9% | 0.3 |
| ER3a_a (R) | 7 | GABA | 151.5 | 18.1% | 0.3 |
| TuBu02 (R) | 5 | ACh | 94 | 11.2% | 0.5 |
| ER3a_d (L) | 3 | GABA | 75.5 | 9.0% | 0.2 |
| ER3a_b (R) | 3 | GABA | 75.5 | 9.0% | 0.1 |
| ER3a_b (L) | 3 | GABA | 71.5 | 8.5% | 0.1 |
| ER3m (R) | 9 | GABA | 46.5 | 5.5% | 0.5 |
| ER3m (L) | 9 | GABA | 34.5 | 4.1% | 0.6 |
| ER3a_d (R) | 2 | GABA | 20.5 | 2.4% | 0.4 |
| ExR1 (L) | 2 | ACh | 14.5 | 1.7% | 0.3 |
| ExR1 (R) | 2 | ACh | 14.5 | 1.7% | 0.4 |
| ER5 (L) | 10 | GABA | 14 | 1.7% | 0.7 |
| ExR7 (R) | 2 | ACh | 11.5 | 1.4% | 0.2 |
| EL (R) | 7 | OA | 8.5 | 1.0% | 0.4 |
| EL (L) | 6 | OA | 7 | 0.8% | 0.4 |
| ER5 (R) | 8 | GABA | 6.5 | 0.8% | 0.6 |
| ExR3 (L) | 1 | 5-HT | 6 | 0.7% | 0.0 |
| ER3a_c (R) | 2 | GABA | 5 | 0.6% | 0.6 |
| ExR2 (L) | 2 | DA | 3 | 0.4% | 0.7 |
| ER3d_e (R) | 3 | GABA | 2.5 | 0.3% | 0.3 |
| ExR7 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| ExR3 (R) | 1 | 5-HT | 2 | 0.2% | 0.0 |
| SMP238 (R) | 1 | ACh | 1.5 | 0.2% | 0.0 |
| CB4183 (R) | 1 | ACh | 1.5 | 0.2% | 0.0 |
| ER3d_e (L) | 2 | GABA | 1.5 | 0.2% | 0.3 |
| PFGs (L) | 1 | unc | 1 | 0.1% | 0.0 |
| ER3d_d (R) | 2 | GABA | 1 | 0.1% | 0.0 |
| ER3d_a (R) | 2 | GABA | 1 | 0.1% | 0.0 |
| ER3a_c (L) | 2 | GABA | 1 | 0.1% | 0.0 |
| ExR2 (R) | 1 | DA | 0.5 | 0.1% | 0.0 |
| ER3d_c (L) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| LAL076 (R) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| ER3d_d (L) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| ER2_c (R) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| ER3d_a (L) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| ER2_a (L) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| ER2_a (R) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| ER2_c (L) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| AOTU046 (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| downstream partner | # | NT | conns ER3a_d | % Out | CV |
|---|---|---|---|---|---|
| ER3a_a (L) | 8 | GABA | 215 | 21.4% | 0.3 |
| ER3a_a (R) | 7 | GABA | 188 | 18.7% | 0.2 |
| ER3m (R) | 9 | GABA | 121.5 | 12.1% | 0.4 |
| ER3m (L) | 9 | GABA | 102 | 10.1% | 0.4 |
| ExR1 (R) | 2 | ACh | 85 | 8.4% | 0.3 |
| ExR1 (L) | 2 | ACh | 82.5 | 8.2% | 0.0 |
| ER3a_d (L) | 3 | GABA | 73 | 7.3% | 0.5 |
| ER3a_b (L) | 3 | GABA | 30 | 3.0% | 0.4 |
| ER3a_b (R) | 3 | GABA | 23.5 | 2.3% | 0.1 |
| ER3a_d (R) | 2 | GABA | 20.5 | 2.0% | 0.4 |
| EL (L) | 9 | OA | 17 | 1.7% | 0.6 |
| EL (R) | 9 | OA | 12.5 | 1.2% | 0.5 |
| ER3d_e (R) | 4 | GABA | 5 | 0.5% | 1.0 |
| ER3a_c (R) | 2 | GABA | 4 | 0.4% | 0.5 |
| EPG (R) | 6 | ACh | 3.5 | 0.3% | 0.3 |
| ER5 (L) | 5 | GABA | 3.5 | 0.3% | 0.3 |
| ER5 (R) | 4 | GABA | 3 | 0.3% | 0.6 |
| ER3d_c (L) | 3 | GABA | 2.5 | 0.2% | 0.3 |
| ER2_a (R) | 2 | GABA | 2 | 0.2% | 0.5 |
| ER3d_d (R) | 1 | GABA | 1.5 | 0.1% | 0.0 |
| ER4d (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| ExR3 (L) | 1 | 5-HT | 1 | 0.1% | 0.0 |
| LNO2 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| ER3d_e (L) | 2 | GABA | 1 | 0.1% | 0.0 |
| ER2_a (L) | 2 | GABA | 1 | 0.1% | 0.0 |
| ER3a_c (L) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| CB4183 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| ER2_c (L) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| ER2_d (L) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| ExR7 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| ExR3 (R) | 1 | 5-HT | 0.5 | 0.0% | 0.0 |
| ER3p_a (R) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| PEG (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| TuBu02 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| ER3d_a (R) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| ER2_d (R) | 1 | GABA | 0.5 | 0.0% | 0.0 |